For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Think Big for COVID-19 vaccine delivery queried by practices wanting vax role
+News
In print
Think Big for COVID-19 vaccine delivery queried by practices wanting vax role
Wednesday 14 April 2021, 02:42 PM

Health minister Andrew Little received his COVID-19 vaccination last week
Anxiety in primary care over the lack of a visible national plan for the largest-yet mass vaccination in New Zealand is turning to frustration. Fiona Cassie and Martin Johnston report
The extent of general practice involvement in delivering the country’s largest mass vaccination programme looks likely to be determined by practice si
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.